Back to News
Market Impact: 0.3

Guru Fundamental Report for JNJ

JNJNDAQ
Company FundamentalsAnalyst InsightsHealthcare & Biotech
Guru Fundamental Report for JNJ

Johnson & Johnson (JNJ) received a 77% rating from Validea's guru fundamental report, utilizing Partha Mohanram's P/B Growth Investor model, which targets low book-to-market stocks with sustained growth characteristics. Although JNJ passed most of the model's financial criteria, it notably failed on "Advertising to Assets" and "Research and Development to Assets," resulting in a score just below the 80% threshold typically indicating "some interest" for the strategy.

Analysis

Johnson & Johnson (JNJ) scores a moderately positive 77% based on Validea's implementation of Partha Mohanram's P/B Growth Investor model, placing it just below the 80% threshold that typically signifies strategic interest. The analysis indicates JNJ is a large-cap growth stock that successfully passes key fundamental tests for a low book-to-market company, including Return on Assets (ROA), Cash Flow from Operations to Assets, and stability metrics like ROA and Sales Variance. However, the model registers critical failures on two forward-looking indicators: Advertising to Assets and Research and Development to Assets. While JNJ exhibits characteristics of a financially healthy and stable company, its lower investment in these specific growth-driving activities, as measured by the model's criteria, prevents it from being classified as a high-conviction pick under this particular growth-focused academic framework.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.50

Ticker Sentiment

JNJ0.70
NDAQ0.00

Key Decisions for Investors

  • Investors should weigh JNJ's strong fundamentals, particularly its passing scores on profitability and cash flow, against the model's specific flags on low R&D and advertising spending, which may temper expectations for aggressive future growth.
  • Growth-focused investors may view the 77% score and the specific failures on growth-driving expenditures as a reason for caution, suggesting the stock might not align with strategies seeking high-momentum names.
  • Given the pass on the book-to-market ratio and robust operational metrics, value or GARP-oriented investors could see an opportunity, interpreting JNJ as a stable company whose fundamental strengths are not fully captured by this specific growth model.